Warning letter
Texas Longhorn RX, LLC: warning letter of Aug 29, 2022
FDA warning letter 639220 · Office of Pharmaceutical Quality Operations, Division II
Key facts
| Reference number | 639220 |
|---|---|
| Company | Texas Longhorn RX, LLC |
| Subject | Compounding Pharmacy/Adulterated Drug Products |
| Issue date | Aug 29, 2022 |
| Posted date | Sep 13, 2022 |
| Issuing office | Office of Pharmaceutical Quality Operations, Division II |
| Product type | Drugs |
| Inspection city | Boerne |
| Inspection ZIP | 78006 |
| Inspection start date | Oct 18, 2021 |
| Letter on fda.gov | fda.gov |
At a glance
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: